Ian Shakil is CSO at Augmedix, Inc. (AUGX). They have made 3 open-market trades across 1 company since 2024, most recently 2024-10-02.
CIK 0001826129
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| AUGX | 11,451 | $27K |
| PrivateUnlisted | 216,660 | — |
| Total | $27K |
Shares reported on the most recent Form 4, priced at the 2024-08-19 close. 1 holding could not be priced and is excluded from the total.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| AUGX | SELL | 2024-05-15 | 2024-05-17 | $1.19 | $2K | -14.6% | -34.1% | +94.0% |
| AUGX | SELL · 10b5-1 | 2024-04-15 | 2024-04-16 | $3.80 | $2K | -18.3% | -64.8% | -74.0% |
| AUGX | SELL · 10b5-1 | 2024-04-12 | 2024-04-15 | $3.82 | $149K | -24.8% | -67.9% | -75.5% |
| AUGX | SELL · 10b5-1 | 2024-04-09 | 2024-04-11 | $3.98 | $738K | -27.7% | -40.5% | -77.2% |
| AUGX | SELL · 10b5-1 | 2024-04-05 | 2024-04-09 | $4.01 | $678K | -25.8% | -38.1% | -75.9% |
| AUGX | SELL · 10b5-1 | 2024-04-03 | 2024-04-04 | $4.13 | $909K | -16.9% | -34.9% | -75.9% |
| AUGX | SELL | 2024-04-01 | 2024-04-03 | $3.90 | $729K | -10.9% | -35.8% | -76.7% |
| AUGX | SELL | 2024-03-28 | 2024-04-09 | $4.06 | $260K | -25.8% | -38.1% | -75.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.